{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:08:16Z","timestamp":1768442896769,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,14]]},"DOI":"10.7759\/cureus.101526","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:30:25Z","timestamp":1768404625000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe 3,4-Methylenedioxymethamphetamine (MDMA)-Associated Rhabdomyolysis in Crohn\u2019s Disease: Direct Toxicity and Inflammatory Susceptibility in the Absence of Hyperthermia"],"prefix":"10.7759","author":[{"given":"Sebastian","family":"Hernandez Mejia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishwarya","family":"Ashwinee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranwa","family":"Aldaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246297","article-title":"Rhabdomyolysis related to acute recreational drug toxicity-a Euro-DEN study","volume":"16","author":"Waldman W","year":"2021","unstructured":"Waldman W, Kabata PM, Dines AM, et al.. Rhabdomyolysis related to acute recreational drug toxicity-a Euro-DEN study. PLoS One. 2021, 16:0246297. 10.1371\/journal.pone.0246297","journal-title":"PLoS One"},{"key":"ref2","article-title":"Ecstasy (MDMA) and its effects on kidneys and their treatment: a review","volume":"19","author":"Bora F","year":"2016","unstructured":"Bora F, Y\u0131lmaz F, Bora T. Ecstasy (MDMA) and its effects on kidneys and their treatment: a review. Iran J Basic Med Sci. 2016, 19:1151-8.","journal-title":"Iran J Basic Med Sci"},{"key":"ref3","article-title":"3,4-methylenedioxymethamphetamine (MDMA) toxicity","author":"Figurasin R","year":"2024","unstructured":"Figurasin R, Lee VR, Maguire NJ. 3,4-methylenedioxymethamphetamine (MDMA) toxicity. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of 'ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall AP","year":"2006","unstructured":"Hall AP, Henry JA. Acute toxic effects of 'ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006, 96:678-85. 10.1093\/bja\/ael078","journal-title":"Br J Anaesth"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021842","article-title":"Protracted hyperthermia and delayed rhabdomyolysis in ecstasy toxicity: a case report","volume":"99","author":"Ghaffari-Rafi A","year":"2020","unstructured":"Ghaffari-Rafi A, Eum KS, Villanueva J, Jahanmir J. Protracted hyperthermia and delayed rhabdomyolysis in ecstasy toxicity: a case report. Medicine (Baltimore). 2020, 99:21842. 10.1097\/MD.0000000000021842","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709744","article-title":"An unusual case of ecstasy poisoning","volume":"22","author":"Hall AP","year":"1996","unstructured":"Hall AP, Lyburn ID, Spears FD, Riley B. An unusual case of ecstasy poisoning. Intensive Care Med. 1996, 22:670-1. 10.1007\/BF01709744","journal-title":"Intensive Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/scan\/nst161","article-title":"MDMA enhances emotional empathy and prosocial behavior","volume":"9","author":"Hysek CM","year":"2014","unstructured":"Hysek CM, Schmid Y, Simmler LD, et al.. MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci. 2014, 9:1645-52. 10.1093\/scan\/nst161","journal-title":"Soc Cogn Affect Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyy047","article-title":"Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics","volume":"21","author":"Luethi D","year":"2018","unstructured":"Luethi D, Liechti ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics. Int J Neuropsychopharmacol. 2018, 21:926-31. 10.1093\/ijnp\/pyy047","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2012.11.020","article-title":"Psychoactive \"bath salts\": not so soothing","volume":"698","author":"Baumann MH","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR. Psychoactive \"bath salts\": not so soothing. Eur J Pharmacol. 2013, 698:1-5. 10.1016\/j.ejphar.2012.11.020","journal-title":"Eur J Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler LD","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, et al.. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013, 168:458-70. 10.1111\/j.1476-5381.2012.02145.x","journal-title":"Br J Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.56","article-title":"In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or \"ecstasy\") and hallucinogen users","volume":"68","author":"Erritzoe D","year":"2011","unstructured":"Erritzoe D, Frokjaer VG, Holst KK, et al.. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or \"ecstasy\") and hallucinogen users. Arch Gen Psychiatry. 2011, 68:562-76. 10.1001\/archgenpsychiatry.2011.56","journal-title":"Arch Gen Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","article-title":"Pharmacology of MDMA in humans","volume":"914","author":"de la Torre R","year":"2000","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, et al.. Pharmacology of MDMA in humans. Ann N Y Acad Sci. 2000, 914:225-37. 10.1111\/j.1749-6632.2000.tb05199.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre R","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, et al.. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004, 26:137-44. 10.1097\/00007691-200404000-00009","journal-title":"Ther Drug Monit"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.092577","article-title":"Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia","volume":"316","author":"Capela JP","year":"2006","unstructured":"Capela JP, Meisel A, Abreu AR, et al.. Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther. 2006, 316:53-61. 10.1124\/jpet.105.092577","journal-title":"J Pharmacol Exp Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/138920110791591535","article-title":"Mechanisms underlying the hepatotoxic effects of ecstasy","volume":"11","author":"Carvalho M","year":"2010","unstructured":"Carvalho M, Pontes H, Remi\u00e3o F, Bastos ML, Carvalho F. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol. 2010, 11:476-95. 10.2174\/138920110791591535","journal-title":"Curr Pharm Biotechnol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0013-9351(02)00051-8","article-title":"Elevated environmental temperature and methamphetamine neurotoxicity","volume":"92","author":"Miller DB","year":"2003","unstructured":"Miller DB, O'Callaghan JP. Elevated environmental temperature and methamphetamine neurotoxicity. Environ Res. 2003, 92:48-53. 10.1016\/s0013-9351(02)00051-8","journal-title":"Environ Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90288-d","article-title":"Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat","volume":"38","author":"Gordon CJ","year":"1991","unstructured":"Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav. 1991, 38:339-44. 10.1016\/0091-3057(91)90288-d","journal-title":"Pharmacol Biochem Behav"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.079236","article-title":"The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis","volume":"313","author":"Rusyniak DE","year":"2005","unstructured":"Rusyniak DE, Tandy SL, Hekmatyar SK, et al.. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis. J Pharmacol Exp Ther. 2005, 313:629-39. 10.1124\/jpet.104.079236","journal-title":"J Pharmacol Exp Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2009.04.057","article-title":"Rhabdomyolysis in MDMA intoxication: a rapid and underestimated killer. \"Clean\" ecstasy, a safe party drug?","volume":"42","author":"Vanden Eede H","year":"2012","unstructured":"Vanden Eede H, Montenij LJ, Touw DJ, Norris EM. Rhabdomyolysis in MDMA intoxication: a rapid and underestimated killer. \"Clean\" ecstasy, a safe party drug?. J Emerg Med. 2012, 42:655-8. 10.1016\/j.jemermed.2009.04.057","journal-title":"J Emerg Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02080508","article-title":"The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney","volume":"3","author":"Campbell GA","year":"2008","unstructured":"Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol. 2008, 3:1852-60. 10.2215\/CJN.02080508","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2174\/138920110791591436","article-title":"Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage","volume":"11","author":"Song BJ","year":"2010","unstructured":"Song BJ, Moon KH, Upreti VV, Eddington ND, Lee IJ. Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Curr Pharm Biotechnol. 2010, 11:434-43. 10.2174\/138920110791591436","journal-title":"Curr Pharm Biotechnol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2022.100075","article-title":"A review on the mitochondrial toxicity of \"ecstasy\" (3,4-methylenedioxymethamphetamine, MDMA)","volume":"3","author":"Capela JP","year":"2022","unstructured":"Capela JP, Carvalho FD. A review on the mitochondrial toxicity of \"ecstasy\" (3,4-methylenedioxymethamphetamine, MDMA). Curr Res Toxicol. 2022, 3:100075. 10.1016\/j.crtox.2022.100075","journal-title":"Curr Res Toxicol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-014-1209-7","article-title":"MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2\/Drp1-dependent manner","volume":"88","author":"Barbosa DJ","year":"2014","unstructured":"Barbosa DJ, Serrat R, Mirra S, et al.. MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2\/Drp1-dependent manner. Arch Toxicol. 2014, 88:1561-72. 10.1007\/s00204-014-1209-7","journal-title":"Arch Toxicol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.03.028","article-title":"Neurotoxicity mechanisms of thioether ecstasy metabolites","volume":"146","author":"Capela JP","year":"2007","unstructured":"Capela JP, Macedo C, Branco PS, et al.. Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience. 2007, 146:1743-57. 10.1016\/j.neuroscience.2007.03.028","journal-title":"Neuroscience"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-145483","article-title":"Time-dependent molecular changes following MDMA-induced nephrotoxicity","volume":"23","author":"Roghani M","year":"2024","unstructured":"Roghani M, Golchoobian R, Mohammadian M, Shanehbandpour-Tabari F, Salehi Z, Gilaki-Bisheh S. Time-dependent molecular changes following MDMA-induced nephrotoxicity. Iran J Pharm Res. 2024, 23:145483. 10.5812\/ijpr-145483","journal-title":"Iran J Pharm Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000146653.68648.0E","article-title":"Rhabdomyolysis associated with Crohn's disease, probably mediated by myositis","volume":"100","author":"Matsuda T","year":"2005","unstructured":"Matsuda T, Inoue S, Furuya H. Rhabdomyolysis associated with Crohn's disease, probably mediated by myositis. Anesth Analg. 2005, 100:898. 10.1213\/01.ANE.0000146653.68648.0E","journal-title":"Anesth Analg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.26.255","article-title":"Rhabdomyolysis associated with Crohn's disease","volume":"26","author":"Chiba M","year":"1987","unstructured":"Chiba M, Igarashi K, Ohta H, Ohtaka M, Arakawa H, Masamune O. Rhabdomyolysis associated with Crohn's disease. Jpn J Med. 1987, 26:255-60. 10.2169\/internalmedicine1962.26.255","journal-title":"Jpn J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.30.441","article-title":"Report of a case of Crohn's disease associated with hyper-creatine phosphokinase-emia","volume":"30","author":"Hayashi K","year":"1991","unstructured":"Hayashi K, Kurisu Y, Ohshiba S, et al.. Report of a case of Crohn's disease associated with hyper-creatine phosphokinase-emia. Jpn J Med. 1991, 30:441-5. 10.2169\/internalmedicine1962.30.441","journal-title":"Jpn J Med"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.121231","article-title":"Rhabdomyolysis associated with Crohn's disease","volume":"455","author":"Tran J","year":"2023","unstructured":"Tran J, Hwang Y. Rhabdomyolysis associated with Crohn's disease. J Neurol Sci. 2023, 455:121231.","journal-title":"J Neurol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein AJ","year":"1976","unstructured":"Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976, 55:401-12. 10.1097\/00005792-197609000-00004","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450866-severe-34-methylenedioxymethamphetamine-mdma-associated-rhabdomyolysis-in-crohns-disease-direct-toxicity-and-inflammatory-susceptibility-in-the-absence-of-hyperthermia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:30:26Z","timestamp":1768404626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450866-severe-34-methylenedioxymethamphetamine-mdma-associated-rhabdomyolysis-in-crohns-disease-direct-toxicity-and-inflammatory-susceptibility-in-the-absence-of-hyperthermia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.101526","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}